Walleye Trading LLC Cytokinetics Inc Put Options Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $1.49 Million - $2.52 Million	-23,300 Reduced 54.31%	19,600 $1.37 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $77,952 - $242,120	2,900 Added 7.25%	42,900 $3.58 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $53,028 - $65,898	1,800 Added 4.71%	40,000 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.25 Million - $1.56 Million	38,200 New	38,200 $1.25 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $425,663 - $608,209	11,900 Added 264.44%	16,400 $751,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $77,080 - $109,040	2,000 Added 80.0%	4,500 $218,000
Q2 2022 Aug 08, 2022	BUY	$33.93 - $48.92 $84,825 - $122,300	2,500 New	2,500 $98,000
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $20,818 - $32,200	-700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $164,880 - $222,624	-4,800 Reduced 87.27%	700 $32,000
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $101,970 - $196,570	5,500 New	5,500 $197,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.